By Dennis Thompson
HealthDay Reporter
THURSDAY, March 9, 2023 (HealthDay News) — Ongoing shortages of a medication that hospitals and emergency rooms rely upon to treat breathing problems are likely to worsen in coming days and weeks, experts warn.
That’s because one of the two major U.S. suppliers of liquid albuterol, Akorn Pharmaceuticals, abruptly laid off its entire workforce and closed plants in New Jersey, New York and Illinois in late February.
“We’re down to just one plant that’s supplying liquid albuterol to all patients in the United States,” said Dr. Juanita Mora, a Chicago allergist/immunologist and volunteer spokesperson for the American Lung Association.
That…
